UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in VKTX — Viking Therapeutics, Inc.
CIK 861177
NEW YORK, NY
Position in VKTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$8,971,243
+$709,536 QoQ
Shares Held
229,973
-9.4% QoQ
Ownership
0.197%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 435 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 30%
Shared 0%
None 70%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,443,898,601 across 206 Biotechnology names. VKTX ranks #42 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in VKTX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,971,243 | 229,973 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $8,261,707 | 253,894 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $8,380,822 | 238,227 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $6,406,167 | 243,766 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $13,490,990 | 509,094 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $11,351,170 | 470,028 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $18,644,474 | 463,332 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $29,897,763 | 472,244 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $25,412,672 | 479,394 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $29,158,216 | 355,588 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $8,841,852 | 475,113 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $5,299,153 | 478,695 | Shares | Defined | 2023-11-13 | |
| 2022-03-31 | $333,477 | 111,159 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $511,329 | 111,159 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $698,076 | 111,159 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $774,075 | 129,228 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $634,016 | 100,240 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $724,243 | 128,640 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $419,853 | 72,140 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $520,128 | 72,140 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $405,582 | 86,663 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||